Shri Ahimsa Naturals' board approved its FY25 Board's Report & a ₹35 Cr investment in its healthcare subsidiary. The board also re-appointed MD Nemi Chand Jain and WTDs Amit Kumar Jain, Dipak Kumar Jain for 3 years, pending shareholder approval at the AGM on Sep 30.